Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients
Clinical trial NCT04762758 · UNKNOWN
Trial details
- NCT number
- NCT04762758
- Sponsor
- Pharnext S.C.A.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-30
- Primary completion
- 2024-04-19
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.